# RESPONSE GENETICS INC

RESPONSE GENETICS INC is a company headquartered in Los Angeles,, CA, United States.

## Company overview

- **Legal name:** RESPONSE GENETICS INC
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Los Angeles,, CA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001124608

## About

RESPONSE GENETICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001124608, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2015-03-31, it reported annual revenue of USD 16,720,327; net income of USD -13,699,362; total assets of USD 13,445,084 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $16.7M (USD 16,720,327)
- **Net income:** -$13.7M (USD -13,699,362)
- **Total assets:** $13.4M (USD 13,445,084)
- **Cash and equivalents:** $2.2M (USD 2,222,491)
- **Operating cash flow:** -$14.3M (USD -14,300,075)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $19.8M (USD 19,801,359)
- **Net income:** -$8.0M (USD -8,020,515)
- **Total assets:** $18.1M (USD 18,058,235)
- **Cash and equivalents:** $8.1M (USD 8,148,599)
- **Operating cash flow:** -$6.5M (USD -6,488,784)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $18.7M (USD 18,736,669)
- **Net income:** -$7.8M (USD -7,757,079)
- **Total assets:** $16.6M (USD 16,589,220)
- **Cash and equivalents:** $9.0M (USD 9,041,478)
- **Operating cash flow:** -$8.0M (USD -8,011,316)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $22.6M (USD 22,642,728)
- **Net income:** -$5.7M (USD -5,702,422)
- **Total assets:** $7.9M (USD 7,850,807)
- **Cash and equivalents:** $1.7M (USD 1,700,295)
- **Operating cash flow:** -$5.1M (USD -5,084,304)

## Recent SEC filings

- Form 8-K — filed 2015-10-14 — period 2015-10-09 — FORM 8-K
- Form 8-K — filed 2015-10-05 — period 2015-10-01 — FORM 8-K
- Form 8-K — filed 2015-08-26 — period 2015-08-24 — FORM 8-K
- Form 8-K — filed 2015-08-11 — period 2015-08-09 — FORM 8-K
- Form 8-K — filed 2015-07-06 — period 2015-07-02 — CURRENT REPORT
- Form 8-K — filed 2015-07-01 — period 2015-06-25 — FORM 8-K
- Form 10-Q — filed 2015-05-15 — period 2015-03-31 — FORM 10-Q
- Form 8-K — filed 2015-05-14 — period 2015-05-14 — FORM 8-K
- Form 8-K — filed 2015-04-08 — period 2015-04-03 — FORM 8-K
- Form 10-K — filed 2015-03-31 — period 2014-12-31 — 10-K
- Form 8-K — filed 2015-03-31 — period 2015-03-31 — FORM 8-K
- Form 8-K — filed 2015-03-20 — period 2015-03-16 — FORM 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/response-genetics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology